Research

July 1, 2020

VUMC-led network to focus on polygenic risk for common diseases

With the aid of a $75 million, five-year grant renewal, the Electronic Medical Records and Genomics Network (eMERGE) will venture beyond its current focus on monogenic disease to scoring research participants’ relative risk for complex heritable diseases such as cardiovascular disease, chronic kidney disease and type 2 diabetes.

By Paul Govern
Gordon Bernard (Steve Green/Vanderbilt)
June 24, 2020

VICTR named to key role to streamline COVID-19 research response

The Vanderbilt Institute for Clinical and Translational Research (VICTR), which provides comprehensive support for clinical and translational research at Vanderbilt University Medical Center (VUMC), has been named Administrative Coordinating Center (ACC) of a national effort to streamline the research response to life-threatening lung and heart problems caused by COVID-19.

By Bill Snyder
June 24, 2020

Study shows better option for treatment of inoperable anal cancer

People with inoperable anal cancer treated with carboplatin-paclitaxel had fewer complications and lived longer than those who received another chemotherapy that has been more often administered.

By Tom Wilemon
June 24, 2020

Study finds zinc doesn’t reduce mortality, other health risks, for heavy alcohol users living with HIV/AIDS

Zinc supplementation did not reduce mortality, cardiovascular risk, levels of inflammation or microbial translocation among people with heavy alcohol use living with HIV/AIDS, according to a Vanderbilt-led study.

By Matt Batcheldor
June 23, 2020

A connection to schizophrenia

The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found.

By Bill Snyder
brain and lightning
June 22, 2020

Single mutation causes seizure disorder

A single mutation in one gene can impair inhibitory signaling in the brain and cause multiple types of seizures and behavioral abnormalities.

By Leigh MacMillan
June 21, 2020

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm. 
By VUMC News and Communications
June 18, 2020

Probing DNA damage repair

After discovering a new mechanism for DNA damage repair last year, Vanderbilt biochemists now provide direct evidence for how it works.
By Leigh MacMillan
June 18, 2020

Studying cells in reduced dimensions

Vanderbilt cell biologists have developed an unbiased, quantitative framework for evaluating single-cell data.
By Bill Snyder
June 18, 2020

All of Us program launches cloud-based research platform

On May 27, the All of Us Research Program launched the beta version of its cloud-based research platform, the Researcher Workbench.
By Paul Govern
June 18, 2020

Bhave, Grome receive awards at Research Forum

Gautam (Jay) Bhave, MD, PhD, assistant professor of Medicine and Cell & Developmental Biology, is the recipient of the 2020 Grant W. Liddle Award for “exemplary leadership in the promotion of scientific research” at Vanderbilt University Medical Center.
By Bill Snyder
June 12, 2020

Robotic technology speeds arrhythmia gene classification

Vanderbilt University Medical Center investigators have used high-throughput robotic technology to rapidly study and classify variations in a gene linked to heart rhythm disorders and cardiac conditions.
By Leigh MacMillan
June 10, 2020

C. diff captures blood cell cofactor to build defensive shield

Vanderbilt University Medical Center scientists have identified a C. diff protein system that senses and captures heme (part of hemoglobin) to build a protective shield that fends off threats from our immune system and antibiotics.
By Leigh MacMillan
1 … 67 68 69 70 71 … 126